MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results.
about
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma.A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
P2860
MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
MACOP-B regimen followed by in ...... ients: 14-year update results.
@en
MACOP-B regimen followed by in ...... ients: 14-year update results.
@nl
type
label
MACOP-B regimen followed by in ...... ients: 14-year update results.
@en
MACOP-B regimen followed by in ...... ients: 14-year update results.
@nl
prefLabel
MACOP-B regimen followed by in ...... ients: 14-year update results.
@en
MACOP-B regimen followed by in ...... ients: 14-year update results.
@nl
P2093
P2860
P1433
P1476
MACOP-B regimen followed by in ...... ients: 14-year update results.
@en
P2093
Albertini P
Barbieri E
Gherlinzoni F
P2860
P304
P356
10.3109/10428190109097718
P577
2001-09-01T00:00:00Z